GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lotus Ventures Inc (XCNQ:J) » Definitions » Cyclically Adjusted Price-to-FCF

Lotus Ventures (XCNQ:J) Cyclically Adjusted Price-to-FCF : (As of Jun. 06, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Lotus Ventures Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Lotus Ventures Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Lotus Ventures's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lotus Ventures Cyclically Adjusted Price-to-FCF Chart

Lotus Ventures Annual Data
Trend Aug13 Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Lotus Ventures Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Lotus Ventures's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Lotus Ventures's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lotus Ventures's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lotus Ventures's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Lotus Ventures's Cyclically Adjusted Price-to-FCF falls into.



Lotus Ventures Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Lotus Ventures's Cyclically Adjusted FCF per Share for the quarter that ended in Aug. 2023 is calculated as:

For example, Lotus Ventures's adjusted Free Cash Flow per Share data for the three months ended in Aug. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Aug. 2023 (Change)*Current CPI (Aug. 2023)
=0/125.3885*125.3885
=0.000

Current CPI (Aug. 2023) = 125.3885.

Lotus Ventures Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201311 0.004 97.182 0.005
201402 -0.003 98.051 -0.004
201405 -0.054 99.394 -0.068
201408 -0.032 99.315 -0.040
201411 -0.018 99.078 -0.023
201502 -0.003 99.078 -0.004
201505 -0.003 100.263 -0.004
201508 -0.002 100.579 -0.002
201511 -0.003 100.421 -0.004
201602 -0.004 100.421 -0.005
201605 -0.008 101.765 -0.010
201608 -0.003 101.686 -0.004
201611 -0.006 101.607 -0.007
201702 -0.005 102.476 -0.006
201705 -0.007 103.108 -0.009
201708 -0.006 103.108 -0.007
201711 -0.012 103.740 -0.015
201802 -0.031 104.688 -0.037
201805 -0.005 105.399 -0.006
201808 -0.063 106.031 -0.075
201811 -0.076 105.478 -0.090
201902 -0.039 106.268 -0.046
201905 -0.026 107.927 -0.030
201908 -0.008 108.085 -0.009
201911 -0.006 107.769 -0.007
202002 -0.001 108.559 -0.001
202005 0.003 107.532 0.003
202008 0.002 108.243 0.002
202011 -0.003 108.796 -0.003
202102 0.002 109.745 0.002
202105 0.000 111.404 0.000
202108 0.004 112.668 0.004
202111 -0.007 113.932 -0.008
202202 -0.003 115.986 -0.003
202205 -0.002 120.016 -0.002
202208 -0.001 120.569 -0.001
202211 -0.009 121.675 -0.009
202302 -0.003 122.070 -0.003
202305 0.000 124.045 0.000
202308 0.000 125.389 0.000

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Lotus Ventures  (XCNQ:J) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Lotus Ventures Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Lotus Ventures's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Lotus Ventures (XCNQ:J) Business Description

Industry
Traded in Other Exchanges
Address
1030 West Georgia Street, Suite 1010, Vancouver, BC, CAN, V6E 2Y3
Lotus Ventures Inc is a licensed cannabis producer that serves customers in Canada. The company created a purpose-built facility with proprietary standard operating procedures to reliably produce rare and high-quality strains of cannabis for consumers looking for a consistent experience.
Executives
Gary Kenneth Mathiesen Senior Officer